Description
Selank + Semax + Pinealon
This three-peptide combination brings together Selank, Semax, and Pinealon, compounds investigated in different areas of neuropeptide and cellular research. Their proposed mechanisms and supporting evidence differ, and research on individual ingredients does not establish the effectiveness of the combined formulation.
How It Works
Semax has been investigated in neurological research, including studies of neurotrophic signaling. Selank has been studied in relation to regulatory peptide activity, while Pinealon is explored in research involving short peptides and cellular regulation. The combined effects of all three remain insufficiently characterized.
POTENTIAL RESEARCH INTEREST
- Neurotrophic pathways: Semax is investigated in selected neurological models.
- Neuropeptide signaling: Selank has been studied in relation to peptide-mediated signaling.
- Short-peptide biology: Pinealon is explored in cellular and neurological research.
- Combination research: The blend presents multiple research variables, but synergy has not been established.
Side Effects and Safety
Reliable safety and efficacy evidence for the complete combination is lacking. Findings for one component should not be used to infer the safety of the other ingredients or the blend.
Dosage
No validated human-use dosage is established for this combination.
Handling & Safety
Verify the identity and documentation of each component and confirm the blend’s stated composition.
Where to Find Selank + Semax + Pinealon
IML provides research information and links to independent suppliers. The selected supplier is responsible for sales and fulfillment.
Affiliate Disclosure: IronMountainLabz does not sell or ship this combination. Links on this page may direct readers to independent suppliers through affiliate links.
